Stock Spotlight Archives

FridayAug 12, 2022 2:53 pm

QualityStocksNewsBreaks – Silo Pharma Inc.’s (SILO) Ketamine Study Generates ‘Extremely Promising’ Data

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, recently completed an animal study of its ketamine formulation, showing nerve pain reduction when administered using a patented delivery system developed in partnership with Zylo Therapeutics. “Results from the small animal study produced positive endpoint results, demonstrating that Silo’s topical ketamine formulation reduced mechanical allodynia and hyperalgesia at both the pre- and post-dosing time points. Mechanical hyperalgesia was additionally reduced on day seven at the pre-dose time point. ‘These positive results of our study show that Silo is able to successfully formulate and deliver ketamine topically at reduced dosage to achieve its…

FridayAug 12, 2022 1:29 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses

Aditxt (NASDAQ: ADTX) has sought to address a medical conundrum: approximately 50% of all transplanted organs are rejected by the host’s body within 10-12 years despite a wide array of medical innovations in recent years. This highlights the critical need for a practical, cost-effective solution to harmful immune responses. Aditxt is looking to solve this medical problem “through the creation of immune reprogramming technologies, which are being developed to retrain the immune system to induce tolerance to transplanted organs, self-tissues (autoimmune diseases) and allergens,” a recent article reads. “While still at a pre-clinical stage, ADi(TM) (Apoptotic DNA Immunotherapy), the company’s…

FridayAug 12, 2022 1:08 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Promoting Artists’ Independence, Revenue Generation

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists. The acquisition completed the company’s flagship offering, Fan Pass Live. “Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution and marketing services without the control of music labels pulling the strings or eating up revenue… The 360-degree suite of Fan Pass Live, Artist Republik and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman,…

FridayAug 12, 2022 12:40 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain. Recently, the company announced that the FDA had approved an amendment to the study’s protocol, boosting its Berubicin clinical development program. “The amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapy,” explains a recent article. “The key objectives of the amendment, according to CNS Pharmaceuticals…

WednesdayAug 10, 2022 3:01 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Increasing Presence on Revolutionary Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) has launched 17 active nodes on the Bitcoin Lightning Network, spanning multiple countries to facilitate faster transactions with lower fees. “The first node (US-West) was launched in November 2021, around the same time the company launched its platform-as-a-service (‘PaaS’) offering, lqwd.tech. LQwD’s PaaS solution allows users worldwide to send and receive Bitcoin on the Lightning Network instantly, securely and inexpensively. The company expects the Lightning Network to be a force for global change and the monetary exchange of the future … with this expectation, it has invested its own Bitcoin assets into the Lightning…

MondayAug 08, 2022 2:58 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Working to Build Framework for Carbon-Negative Energy Production

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and renewable natural gas (“RNG”) platform, is working to develop the sustainable infrastructure that contributes to carbon-negative energy production. “EverGen has been methodically and quickly expanding its footprint across Canada under the moniker of ‘Canada’s Renewable Natural Gas Infrastructure Platform.’ At the end of December 2020, EverGen raised over $30 million and acquired two RNG projects in British Columbia to get operations rolling. In 2021, EverGen bought Fraser Valley Biogas Ltd., nailed down offtake agreements for its RNG with FortisBC, a unit of Newfoundland-based Fortis Inc., Canada’s biggest private…

FridayAug 05, 2022 1:30 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc. Standing Distinct in Battle Against Rising Global Temperatures

GeoSolar Technologies is taking an innovative approach to redefining how people heat, cool, cook, power, and purify homes with 100% sustainable energy sources. “In fact, ‘There may not be a company in the climate technology industry that is doing more in the battle against rising global temperatures,’ according to Marilyn Lopez, partner and co-founder of TAG Collective. TAG is overseeing marketing efforts for GeoSolar Technologies related to the company’s upcoming Reg A+ offering to raise capital ahead of going public,” a recent article reads. “The Denver-based company’s patent-pending SmartGreen(TM) system harnesses energy from the earth and sun to naturally power…

FridayAug 05, 2022 1:20 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Continues Strides to Push Gross Margins by Optimizing Product Offerings

FingerMotion (NASDAQ: FNGR) reported a 37% year-over-year growth in revenue for the financial year ended Feb. 28, 2022 (“FY2022”). “One of our key initiatives is to keep pushing gross margins higher, and we have been quite successful by optimizing our product offerings,” a recent article quotes CEO Martin Shen’s comments from the release of the FY2022 results. Regarding the results, Shen is quoted saying, “We have been able to steadily increase our margins by optimizing our product mix between Top-up and SMS. While our biggest challenge continues to be access to non-dilutive capital, we remain steadfast in our belief that…

FridayAug 05, 2022 1:02 pm

QualityStocksNewsBreaks – Why Cub Crafters Inc. Is ‘One to Watch’

Cub Crafters (typically styled CubCrafters), based at McAllister Field Airport in Yakima, Washington, is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “The company was founded in 1980 to build parts and supplementary type certificate (‘STC’) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (‘FAA’) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production…

ThursdayAug 04, 2022 1:14 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes

Silo Pharma (OTCQB: SILO) recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage Laboratories, a contract research organization (“CRO”). “Recent research by the company revealed that SPU-21 liposomes have the ability to target inflamed epithelium, suggesting they can be used to target drug delivery. Further, SPU-21 can potentially be used to develop fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis. According to the research, this approach may enhance therapeutic effects and decrease potential toxicity despite systemic administration of the drug,” a recent article reads. “In addition, Silo recently announced…

Site Search

Company Search

Category: Stock Spotlight